Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies.
Chun XuAnnika Verena GoßCarmen DorneburgKlaus-Michael DebatinJiwu WeiChristian Beltinger
Published in: Oncolytic virotherapy (2018)
We prove the principle that a non-replicating OMV can serve as a "decoy" for neutralizing anti-MV antibodies, thereby allowing antitumor activity of OMV.